Technology

FDA halts Avandia trial enrollment

The U.S. Food and Drug Administration (FDA) notified GlaxoSmithKline that the post-marketing trial of Avandia (rosiglitazone) is on “partial clinical hold,” meaning no new…
flu-vaccine

Issues up close

ANA’s “Bringing Immunity to Every Community” campaign aims to boost RNs’ knowledge of immunization, encourage them to get vaccinated, and position them as leading…

Technology: The great enabler

Where would you be without a “smart” phone to manage your life? We’ve adapted to noxious ring tones; how have we adapted to technology…

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at…

Digital dashboards and staffing

Many healthcare organizations use digital “dashboards” to provide employees with real-time data collected from various sources, helping to guide decisions and improve the quality…

Genetic/Genomic Competency Center

The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses and physician…

FDA clears STERIS system

On April 5, the U.S. Food and Drug Administration cleared the STERIS System 1E Liquid Chemical Sterilant Processing System. The device is used to…

FDA approves new device for asthma

On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma…

FDA halts Avandia trial enrollment

The U.S. Food and Drug Administration (FDA) notified GlaxoSmithKline that the post-marketing trial of Avandia (rosiglitazone) is on “partial clinical hold,” meaning…
flu-vaccine

Issues up close

ANA’s “Bringing Immunity to Every Community” campaign aims to boost RNs’ knowledge of immunization, encourage them to get vaccinated, and position them…

Technology: The great enabler

Where would you be without a “smart” phone to manage your life? We’ve adapted to noxious ring tones; how have we adapted…

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who…

Digital dashboards and staffing

Many healthcare organizations use digital “dashboards” to provide employees with real-time data collected from various sources, helping to guide decisions and improve…

Genetic/Genomic Competency Center

The Genetic/Genomic Competency Center (G2C2, http://www.g-2-c-2.org/) is a new free online resource created to help educators teach the next generation of nurses…

FDA clears STERIS system

On April 5, the U.S. Food and Drug Administration cleared the STERIS System 1E Liquid Chemical Sterilant Processing System. The device is…

FDA approves new device for asthma

On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and…

Poll

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.